Company Filing History:
Years Active: 2015-2016
Title: **Innovator Soma Ghosh: Pioneering Advancements in Protein Kinase Inhibitors**
Introduction
Soma Ghosh, an esteemed inventor located in Ganguly Bagan, India, has showcased her ingenuity through a remarkable portfolio of patents. With a focus on advancing medical science, Ghosh has contributed to innovations aimed at treating significant health conditions through her work in pharmaceutical compositions.
Latest Patents
Soma Ghosh holds two notable patents, one of which centers around the development of heterocyclic compounds as protein kinase inhibitors. This invention presents a heterocyclic compound of formula (I), along with its pharmaceutically acceptable salts, prodrugs, or hydrates. This compound is particularly significant as it is designed to treat or prevent diseases associated with protein kinases, most notably focusing on the Janus Kinase family. The patent encompasses comprehensive methods for production and application of the compound, emphasizing its utility in modern medical treatments.
Career Highlights
Ghosh currently works at Daiichi Sankyo Company, Limited, a global leader in pharmaceutical innovation. Her research and inventions play a vital role in the company's efforts to develop advanced therapies, enabling better health outcomes for patients worldwide. Ghosh's work underlines the intersection of scientific research and practical application in medicine, cementing her reputation as a prominent inventor.
Collaborations
Throughout her career, Ghosh has collaborated with notable professionals such as Ashwani Kumar Verma and Kumaragurubaran Nagaswamy. These collaborations further enhance the breadth of her research and innovation, allowing for a multidisciplinary approach to tackling complex medical challenges.
Conclusion
Soma Ghosh stands out as a significant figure in the realm of pharmaceutical innovations. Her contributions through patents focused on protein kinase inhibitors not only advance scientific knowledge but also pave the way for improved therapeutic solutions. With her ongoing work at Daiichi Sankyo Company, Limited, the potential for impactful healthcare advancements remains promising.